Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
After finishing at $21.31 in the prior trading day, Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) closed at $20.19, down -5.26%. In other words, the price has decreased by -$5.26 from its previous closing price. On the day, 1.22 million shares were traded. CPRX stock price reached its highest trading level at $21.3 during the session, while it also had its lowest trading level at $20.03.
Ratios:
Our goal is to gain a better understanding of CPRX by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.39 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 12.68. For the most recent quarter (mrq), Quick Ratio is recorded 4.92 and its Current Ratio is at 5.11. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stephens on November 18, 2024, initiated with a Overweight rating and assigned the stock a target price of $35.
On March 14, 2024, Citigroup started tracking the stock assigning a Buy rating and target price of $27.
On March 07, 2024, BofA Securities started tracking the stock assigning a Buy rating and target price of $23.BofA Securities initiated its Buy rating on March 07, 2024, with a $23 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 10 ’24 when Miller Steve sold 50,000 shares for $21.93 per share. The transaction valued at 1,096,350 led to the insider holds 686,996 shares of the business.
Miller Steve bought 50,000 shares of CPRX for $1,096,333 on Dec 10 ’24. On Nov 27 ’24, another insider, INGENITO GARY, who serves as the Chief Med. & Reg. Officer of the company, sold 12,000 shares for $22.72 each. As a result, the insider received 272,654 and left with 51,391 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CPRX now has a Market Capitalization of 2408121856 and an Enterprise Value of 1969081728. As of this moment, Catalyst’s Price-to-Earnings (P/E) ratio for their current fiscal year is 17.23, and their Forward P/E ratio for the next fiscal year is 12.98. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.28. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.18 while its Price-to-Book (P/B) ratio in mrq is 3.64. Its current Enterprise Value per Revenue stands at 4.276 whereas that against EBITDA is 9.313.
Stock Price History:
The Beta on a monthly basis for CPRX is 0.79, which has changed by 0.39372134 over the last 52 weeks, in comparison to a change of 0.24933672 over the same period for the S&P500. Over the past 52 weeks, CPRX has reached a high of $24.27, while it has fallen to a 52-week low of $13.12. The 50-Day Moving Average of the stock is -7.24%, while the 200-Day Moving Average is calculated to be 9.10%.
Shares Statistics:
The stock has traded on average 889.94K shares per day over the past 3-months and 727650 shares per day over the last 10 days, according to various share statistics. A total of 119.27M shares are outstanding, with a floating share count of 105.49M. Insiders hold about 11.55% of the company’s shares, while institutions hold 75.90% stake in the company. Shares short for CPRX as of 1734048000 were 5940869 with a Short Ratio of 6.68, compared to 1731628800 on 5679308. Therefore, it implies a Short% of Shares Outstanding of 5940869 and a Short% of Float of 6.18.
